These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9390784)

  • 21. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
    Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
    J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
    de la Monte SM; Volicer L; Hauser SL; Wands JR
    Ann Neurol; 1992 Dec; 32(6):733-42. PubMed ID: 1471863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cortisol levels in aging and Alzheimer's disease in postmortem cerebrospinal fluid.
    Swaab DF; Raadsheer FC; Endert E; Hofman MA; Kamphorst W; Ravid R
    J Neuroendocrinol; 1994 Dec; 6(6):681-7. PubMed ID: 7894471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removal of activated complement from shed blood: comparison of high- and low-dilutional haemofiltration.
    Arnestad JP; Hyllner M; Bengtson JP; Tylman M; Mollnes TE; Bengtsson A
    Acta Anaesthesiol Scand; 1998 Aug; 42(7):811-5. PubMed ID: 9698958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Alzheimer's disease and normal aging on cerebrospinal fluid norepinephrine responses to yohimbine and clonidine.
    Peskind ER; Wingerson D; Murray S; Pascualy M; Dobie DJ; Le Corre P; Le Verge R; Veith RC; Raskind MA
    Arch Gen Psychiatry; 1995 Sep; 52(9):774-82. PubMed ID: 7654129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement activation in prestorage leucocyte-filtered plasma.
    Hyllner M; Tylman M; Bengtson JP; Rydberg L; Bengtsson A
    Transfus Med; 2004 Feb; 14(1):45-52. PubMed ID: 15043593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF d-serine concentrations are similar in Alzheimer's disease, other dementias, and elderly controls.
    Biemans EA; Verhoeven-Duif NM; Gerrits J; Claassen JA; Kuiperij HB; Verbeek MM
    Neurobiol Aging; 2016 Jun; 42():213-6. PubMed ID: 27143438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid epinephrine in Alzheimer's disease and normal aging.
    Peskind ER; Elrod R; Dobie DJ; Pascualy M; Petrie E; Jensen C; Brodkin K; Murray S; Veith RC; Raskind MA
    Neuropsychopharmacology; 1998 Dec; 19(6):465-71. PubMed ID: 9803422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer's Disease.
    Zimetti F; Caffarra P; Ronda N; Favari E; Adorni MP; Zanotti I; Bernini F; Barocco F; Spallazzi M; Galimberti D; Ricci C; Ruscica M; Corsini A; Ferri N
    J Alzheimers Dis; 2017; 55(1):315-320. PubMed ID: 27662294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-dependent decline in the apolipoprotein E level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease.
    Fukuyama R; Mizuno T; Mori S; Yanagisawa K; Nakajima K; Fushiki S
    Eur Neurol; 2000; 43(3):161-9. PubMed ID: 10765057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CSF complement proteins are elevated in prodromal to moderate Alzheimer's disease patients and are not altered by the anti-tau antibody semorinemab.
    Sandoval C; Lee J; Toth B; Nagaraj R; Schauer SP; Hoffman J; Calderon E; Kollmorgen G; Sanabria Bohórquez SM; Monteiro C; Teng E; Hanson JE; Yeh FL; Gutierrez J; Biever A
    Alzheimers Dement; 2024 Nov; 20(11):7940-7953. PubMed ID: 39369294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF markers related to pathogenetic mechanisms in Alzheimer's disease.
    Mulder C; Schoonenboom SN; Wahlund LO; Scheltens P; van Kamp GJ; Veerhuis R; Hack CE; Blomberg M; Schutgens RB; Eikelenboom P
    J Neural Transm (Vienna); 2002 Dec; 109(12):1491-8. PubMed ID: 12486489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and cerebrospinal fluid proteins and the blood-brain barrier in Alzheimer's disease and multi-infarct dementia.
    Elovaara I; Palo J; Erkinjuntti T; Sulkava R
    Eur Neurol; 1987; 26(4):229-34. PubMed ID: 3595662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
    Diamandis EP; Scorilas A; Kishi T; Blennow K; Luo LY; Soosaipillai A; Rademaker AW; Sjogren M
    Clin Biochem; 2004 Mar; 37(3):230-7. PubMed ID: 14972646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement activation products in acute heart failure: Potential role in pathophysiology, responses to treatment and impacts on long-term survival.
    Trendelenburg M; Stallone F; Pershyna K; Eisenhut T; Twerenbold R; Wildi K; Dubler D; Schirmbeck L; Puelacher C; Rubini Gimenez M; Sabti Z; Osswald L; Breidthardt T; Müller C
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):348-357. PubMed ID: 29064269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocyte tissue factor expression and ongoing complement generation in ventricular assist device patients.
    Wilhelm CR; Ristich J; Kormos RL; Wagner WR
    Ann Thorac Surg; 1998 Apr; 65(4):1071-6. PubMed ID: 9564930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-dependent change in the levels of Abeta40 and Abeta42 in cerebrospinal fluid from control subjects, and a decrease in the ratio of Abeta42 to Abeta40 level in cerebrospinal fluid from Alzheimer's disease patients.
    Fukuyama R; Mizuno T; Mori S; Nakajima K; Fushiki S; Yanagisawa K
    Eur Neurol; 2000; 43(3):155-60. PubMed ID: 10765056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
    Heslegrave A; Heywood W; Paterson R; Magdalinou N; Svensson J; Johansson P; Öhrfelt A; Blennow K; Hardy J; Schott J; Mills K; Zetterberg H
    Mol Neurodegener; 2016 Jan; 11():3. PubMed ID: 26754172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).
    Blaabjerg M; Hemdrup AL; Drici L; Ruprecht K; Garred P; Höftberger R; Kristensen BW; Kondziella D; Sejbaek T; Hansen SW; Nielsen HH; Jensen P; Meyer M; Paul F; Lassmann H; Larsen MR; Illes Z
    Front Immunol; 2018; 9():741. PubMed ID: 29740431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.